Texas Codes homeSearch Texas
Tex. CodesHuman Resources CodeTitle 2. Human Services and Protective Services in GeneralSubtitle C. Assistance ProgramsChapter 36. Health Care Program Fraud Prevention

Tex. Hum. Res. Code § 36.102 (2026)

Initiation Of Action; Consent Required For Dismissal

Edition and currency
laws through the 89th Legislature (2025). The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTlaws through the 89th Legislature (2025) ACTIVE · 11 IN 5Y cited 2008–2026 14citing cases
At a glance

Courts have cited this section in 14 opinions since 2008, 11 of them in the last five years. The most litigated part is subsection (a) (6 cases).

Sec. 36.102. INITIATION OF ACTION; CONSENT REQUIRED FOR DISMISSAL. (a) A person bringing an action under this subchapter shall serve a copy of the petition and a written disclosure of substantially all material evidence and information the person possesses on the attorney general in compliance with the Texas Rules of Civil Procedure.

(b) The petition shall be filed in camera and, except as provided by Subsection (c-1) or (d), shall remain under seal until at least the 180th day after the date the petition is filed or the date on which the state elects to intervene, whichever is earlier. The petition may not be served on the defendant until the court orders service on the defendant.

(c) The state may elect to intervene and proceed with the action not later than the 180th day after the date the attorney general receives the petition and the material evidence and information.

(c-1) At the time the state intervenes, the attorney general may file a motion with the court requesting that the petition remain under seal for an extended period.

(d) The state may, for good cause shown, move the court to extend the 180-day deadline under Subsection (b) or (c). A motion under this subsection may be supported by affidavits or other submissions in camera.

(e) An action under this subchapter may be dismissed only if the court and the attorney general consent in writing to the dismissal and state their reasons for consenting.

Added by Acts 1997, 75th Leg., ch. 1153, Sec. 4.08, eff. Sept. 1, 1997.

Amended by:

Acts 2005, 79th Leg., Ch. 806 (S.B. 563), Sec. 10, eff. September 1, 2005.

Acts 2019, 86th Leg., R.S., Ch. 97 (H.B. 2004), Sec. 1, eff. September 1, 2019.

Acts 2019, 86th Leg., R.S., Ch. 97 (H.B. 2004), Sec. 2, eff. September 1, 2019.

The 14 cases that cite Tex. Hum. Res. Code § 36.102 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENUnited States ex rel. Foster v. Bristol-Myers Squibb Co., 587 F. Supp. 2d 805 (E.D. Tex. 2008).
cites § 36.102 2×subsections: (a) (c)cited by 16 cases
Where it cites § 36.102
“” Tex. Hum. Res.Code § 36.102(a) (Vernon 1997).”
2
GREENRichard J. Malouf v. State, 461 S.W.3d 641 (Tex. App.—Austin 2015).
cites § 36.102 1×cited by 4 cases
Where it cites § 36.102
“3d at 396 ; compare Tex. Hum. Res. Code § 36.102 (addressing initiation of action by filing in camera petition and serving attorney general with petition to remain under seal for 180 days or until State intervénes and prohibiting service of petition on defendant until the court…”
Later courts cite it for
“under the common law, there is a longstanding interpretive presumption that 'person' does not include the sovereign, which may be disregarded only upon some affirmative showing of statutory intent to the contrary.” · 2 citing courts
3
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
cites § 36.102 24×subsections: (a) 5× (b) 4× (e) 4× (d) 2×cited by 0 cases
Where it cites § 36.102
“V, § 21 498 Tex. Hum. Res. Code § 36.101 499 Tex. Hum.”
4
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
cites § 36.102 17×subsections: (e) 6× (c) 3× (a) 2×cited by 0 cases
Where it cites § 36.102
“3 Tex. Hum. Res. Code Ann. § 36.101 (a)....”
5
GREENIn re Sanofi-Aventis U.S. LLC v. the State of Texas, 711 S.W.3d 732 (Tex. App.—15th Dist. 2025).
cites § 36.102 3×subsections: (a)cited by 0 cases
Where it cites § 36.102
“36-37, is overblown because the Act ensures that the Attorney General may review, take over, and oth- erwise control the lawsuit from its inception, Tex. Hum. Res. Code §§ 36.102, 36.107. Indeed, the Attorney General can dismiss a meritless action over the objection of the qui…”
The case’s holding
A notice of supplemental authority attaching the State's merits brief in a qui tam suit is not a reasoned ruling; it notes the relator apparently recognized a deficiency of proof on venue.
6
NO FLAGIn re AstraZeneca Pharm. LP v. the State of Texas, No. 15-25-00088-CV (Tex. App.—15th Dist. Aug. 20, 2025).
cites § 36.102 7×subsections: (e) 2×cited by 0 cases
Summary
No passage or summary on file for this case yet.
7
NO FLAGFrey v. Health Mgmt. Sys. Inc, No. 3:19-cv-00920 (N.D. Tex. Dec. 6, 2022).
cites § 36.102 2×subsections: (b) 2×cited by 0 casesunknown
Where it cites § 36.102
“Unseal, ¶ 5; Tex. Hum. Res. Code § 36.102(b). While Frey’s qui tam action was pending in state court, the State of Texas was also litigating a series of other lawsuits against various defendants—not including HMS—relating to Medicaid fraud, among other allegations (the “Xerox…”
8
NO FLAGState of Texas ex rel. Joshua LaFountain v. BLT Mgmt. Co., No. 15-25-00067-CV (Tex. App.—15th Dist. Sept. 19, 2025).
cites § 36.102 2×subsections: (b) (c)cited by 0 cases
Where it cites § 36.102
“49 Tex. Hum. Res. Code § 36.002(13)………………………………………………51 Tex.”
9
NO FLAGState of Texas v. Christine Ellis, No. 03-22-00236-CV (Tex. App.—Austin June 8, 2022).
cites § 36.102 1×cited by 0 cases
Where it cites § 36.102
“See Tex. Hum. Res. Code § 36.102 (requiring qui tam petitions to be filed under seal under Texas Medicaid Fraud Prevention Act).”
10
NO FLAGFrey v. Health Mgmt. Sys. Inc, No. 3:19-cv-00920 (N.D. Tex. May 2, 2023).
cites § 36.102 1×subsections: (b)cited by 0 casesunknown
Where it cites § 36.102
“, 2; Tex. Hum. Res. Code § 36.102(b). Ultimately, the State of Texas and Frey entered a settlement agreement in which Frey signed a release of claims.”
11
NO FLAGIn re Sanofi-Aventis U.S. LLC v. the State of Texas, 711 S.W.3d 732 (Tex. App.—15th Dist. 2025).
cites § 36.102 1×subsections: (c)cited by 0 cases
Where it cites § 36.102
“Tex. Hum. Res. Code §§ 36.102(c)–(e), .104(a)–(b), .”
12
NO FLAGState of Texas v. Alexandra Alvarez, No. 15-25-00034-CV (Apr. 7, 2026).
cites § 36.102 1×subsections: (a)cited by 0 cases
Where it cites § 36.102
“Tex. Hum. Res. Code § 36.102(a). The State has the option to intervene in such a qui tam suit or decline to take over the action.”
13
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Apr. 30, 2026).
cites § 36.102 1×subsections: (a)cited by 0 cases
Where it cites § 36.102
“104 TEX. HUM. RES. CODE § 36.104. 23 discretion to decide whether allowing a private party to proceed unilaterally to exercise uniquely public duties violates the Texas Constitution; that is ultimately for courts.”
14
NO FLAGDr. Behzad Nazari v. State, No. 03-15-00252-CV (Tex. App.—Austin Aug. 10, 2015).
cites § 36.102 1×cited by 0 cases
Where it cites § 36.102
“Tex. Hum. Res. Code §§ 36.102, 36.104, 36.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200820172026

One bar per year. Tallest: 6 cases in 2025. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Tex. App.9txctapp152N.D. Tex.2E.D. Tex.1
By subsection
(a)6 cases
United States ex rel. Foster v. Bristol-Myers Squibb Co., 587 F. Supp. 2d 805 (E.D. Tex. 2008).“” Tex. Hum. Res.Code § 36.102(a) (Vernon 1997).”
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).“V, § 21 498 Tex. Hum. Res. Code § 36.101 499 Tex. Hum.”
In re Sanofi-Aventis U.S. LLC v. the State of Texas, 711 S.W.3d 732 (Tex. App.—15th Dist. 2025).“36-37, is overblown because the Act ensures that the Attorney General may review, take over, and oth- erwise control the lawsuit from its inception, Tex. Hum. Res. Code §§ 36.102, 36.107. Indeed, the Attorney General can dismiss a meritless action over the objection of the qui…”
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).“3 Tex. Hum. Res. Code Ann. § 36.101 (a)....”
State of Texas v. Alexandra Alvarez, No. 15-25-00034-CV (Apr. 7, 2026).“Tex. Hum. Res. Code § 36.102(a). The State has the option to intervene in such a qui tam suit or decline to take over the action.”
Showing the top 5 of 6. More in the list view →
(b)4 cases
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
Frey v. Health Mgmt. Sys. Inc, No. 3:19-cv-00920 (N.D. Tex. Dec. 6, 2022).“Unseal, ¶ 5; Tex. Hum. Res. Code § 36.102(b). While Frey’s qui tam action was pending in state court, the State of Texas was also litigating a series of other lawsuits against various defendants—not including HMS—relating to Medicaid fraud, among other allegations (the “Xerox…”
Frey v. Health Mgmt. Sys. Inc, No. 3:19-cv-00920 (N.D. Tex. May 2, 2023).“, 2; Tex. Hum. Res. Code § 36.102(b). Ultimately, the State of Texas and Frey entered a settlement agreement in which Frey signed a release of claims.”
State of Texas ex rel. Joshua LaFountain v. BLT Mgmt. Co., No. 15-25-00067-CV (Tex. App.—15th Dist. Sept. 19, 2025).“49 Tex. Hum. Res. Code § 36.002(13)………………………………………………51 Tex.”
(c)5 cases
United States ex rel. Foster v. Bristol-Myers Squibb Co., 587 F. Supp. 2d 805 (E.D. Tex. 2008).
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
State of Texas ex rel. Joshua LaFountain v. BLT Mgmt. Co., No. 15-25-00067-CV (Tex. App.—15th Dist. Sept. 19, 2025).
In re Sanofi-Aventis U.S. LLC v. the State of Texas, 711 S.W.3d 732 (Tex. App.—15th Dist. 2025).“Tex. Hum. Res. Code §§ 36.102(c)–(e), .104(a)–(b), .”
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
(d)1 case
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
(e)3 cases
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
In re AstraZeneca Pharm. LP v. the State of Texas, No. 15-25-00088-CV (Tex. App.—15th Dist. Aug. 20, 2025).
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: laws through the 89th Legislature (2025). Syfert holds no earlier or later version of this section.

Texas Codes Home  |  Search Texas  |  Search cases for this section  |  syfert.com